Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Treasury Shares (2016 - 2026)

Cumberland Pharmaceuticals' Treasury Shares history spans 16 years, with the latest figure at $58947.0 for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 82.62% to $58947.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $58947.0, a 82.62% decrease, with the full-year FY2025 number at $58947.0, down 82.62% from a year prior.
  • Treasury Shares hit $58947.0 in Q4 2025 for Cumberland Pharmaceuticals, roughly flat from $58947.0 in the prior quarter.
  • Over the last five years, Treasury Shares for CPIX hit a ceiling of $568181.0 in Q4 2021 and a floor of $1800.0 in Q2 2025.
  • Historically, Treasury Shares has averaged $159100.4 across 5 years, with a median of $95390.5 in 2021.
  • Biggest five-year swings in Treasury Shares: skyrocketed 252.05% in 2023 and later plummeted 97.66% in 2025.
  • Tracing CPIX's Treasury Shares over 5 years: stood at $568181.0 in 2021, then crashed by 30.35% to $395751.0 in 2022, then tumbled by 34.16% to $260566.0 in 2023, then surged by 30.18% to $339200.0 in 2024, then plummeted by 82.62% to $58947.0 in 2025.
  • Business Quant data shows Treasury Shares for CPIX at $58947.0 in Q4 2025, $58947.0 in Q3 2025, and $1800.0 in Q2 2025.